Semi-Annual Consolidated Statement Of Comprehensive Income

ROHTO PHARMACEUTICAL CO.,LTD. - Filing #7249269

Concept 2024-04-01 to
2025-03-31
2024-04-01 to
2025-03-31
2024-04-01 to
2025-03-31
2024-04-01 to
2025-03-31
2024-04-01 to
2025-03-31
2023-04-01 to
2024-03-31
2023-04-01 to
2024-03-31
2023-04-01 to
2024-03-31
2023-04-01 to
2024-03-31
2023-04-01 to
2024-03-31
Semi-annual consolidated statement of comprehensive income
Statement of comprehensive income
Profit (loss)
18,860,000,000 JPY
18,860,000,000 JPY
18,860,000,000 JPY
30,951,000,000 JPY
18,860,000,000 JPY
19,970,000,000 JPY
31,394,000,000 JPY
19,970,000,000 JPY
19,970,000,000 JPY
19,970,000,000 JPY
Other comprehensive income
Valuation difference on available-for-sale securities
-1,809,000,000 JPY
3,376,000,000 JPY
Foreign currency translation adjustment
5,034,000,000 JPY
8,003,000,000 JPY
Remeasurements of defined benefit plans, net of tax
834,000,000 JPY
869,000,000 JPY
Share of other comprehensive income of entities accounted for using equity method
1,000,000 JPY
4,000,000 JPY
Other comprehensive income
4,060,000,000 JPY
12,253,000,000 JPY
Comprehensive income
35,012,000,000 JPY
43,647,000,000 JPY
Comprehensive income attributable to
Comprehensive income attributable to owners of parent
35,249,000,000 JPY
43,075,000,000 JPY
Comprehensive income attributable to non-controlling interests
-236,000,000 JPY
572,000,000 JPY

Talk to a Data Expert

Have a question? We'll get back to you promptly.